The Week in Business: The Truth About Drug Costs, and Uber’s Disappointing I.P.O.
Plus, the continuing trade drama with China, and a pledge to end extremist content online.
Plus, the continuing trade drama with China, and a pledge to end extremist content online.
Plus, Stephen Moore won’t be nominated for a Fed seat after all — but why?
Plus, The National Enquirer is for sale, and Elon Musk must make nice with the S.E.C.
The talks precede Uber’s initial public offering and may ease worries about how costly it is to develop autonomous vehic...